Equillium Inc
IPO News: File S-1: Equillium Inc files $86mm IPO
Equillium Inc

Equillium Inc

NASDAQ: EQ

Initial Filing Date:  09/17/18

Size:  $86.3mm

Bookrunners:  Jefferies | Leerink | Stifel

Major Holders:  Biocon | BioBrit | Steel Family Revocable Trust | Stephen Connelly

Description: Equillium is a biotechnology company leveraging deep understanding of immunobiology to develop products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need.

Note: Emerging Growth Company

Reference Link:  S-1